Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions

O. Alagoz, D. Durham, K. Kasirajan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions'. Together they form a unique fingerprint.

Medicine & Life Sciences